Treatment of severe lichen planus with the JAK inhibitor tofacitinib.

William Damsky,Alice Wang,Brianna Olamiju,Danielle Peterson,Anjela Galan,Brett King

The Journal of allergy and clinical immunology（2020）

引用 37|浏览10

暂无评分

摘要

Lichen planus (LP) is frequently difficult to treat. Here we show that JAK-STAT signaling is activated in LP and that treatment with a JAK inhibitor, tofacitinib, was effective in 3 patients with recalcitrant erosive LP.

查看译文

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要